FGF21 and obesity due to melanocortin 4 receptor deficiency: Over-expression or treatment with recombinant FGF21 protects mice from development of obesity and fatty liver and improves insulin sensitivity [3] and comparable metabolic benefits are also observed in rhesus monkeys [14].